103 related articles for article (PubMed ID: 1146651)
1. Relationship between animal models and clinical parkinsonism.
Marsden CD; Duvoisin RC; Jenner P; Parkes JD; Pycock C; Tarsy D
Adv Neurol; 1975; 9():165-75. PubMed ID: 1146651
[No Abstract] [Full Text] [Related]
2. [The reserpine model of parkinsonism and changes in the metabolism of mediators].
Tret'iakova KA; Samoĭlova ZT
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):220-4. PubMed ID: 4743272
[No Abstract] [Full Text] [Related]
3. Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.
Ungerstedt U; Ljungberg T; Steg G
Adv Neurol; 1974; 5():421-6. PubMed ID: 4531217
[No Abstract] [Full Text] [Related]
4. [L-threo-DOPS therapy and parkinsonism].
Narabayashi H
No To Shinkei; 1986 Jan; 38(1):60-2. PubMed ID: 3083844
[No Abstract] [Full Text] [Related]
5. Parkinsonism: animal analogues of the human disorder.
Duvoisin RC
Res Publ Assoc Res Nerv Ment Dis; 1976; 55():293-303. PubMed ID: 826997
[No Abstract] [Full Text] [Related]
6. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic agonists in animal models of parkinsonism.
Poirier LJ
Adv Neurol; 1975; 9():327-35. PubMed ID: 807089
[No Abstract] [Full Text] [Related]
8. Drug-induced changes in brain dopamine and their relation to parkinsonism.
Vogt M
Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
[No Abstract] [Full Text] [Related]
9. Biochemical and pharmacological aspects of Parkinsonism.
Carlsson A
Acta Neurol Scand Suppl; 1972; 51():11-42. PubMed ID: 4351191
[No Abstract] [Full Text] [Related]
10. [Modeling parkinsonism (review)].
Atadzhanov M
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):110-9. PubMed ID: 6805182
[No Abstract] [Full Text] [Related]
11. [Biochemical bases of Parkinson disease].
Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
[No Abstract] [Full Text] [Related]
12. [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].
Luquin MR; Obeso JA; Herrero MT; Laguna J; Martínez-Lage JM
Neurologia; 1991 Oct; 6(8):287-94. PubMed ID: 1790005
[TBL] [Abstract][Full Text] [Related]
13. Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
Olson L; Backlund EO; Gerhardt G; Hoffer B; Lindvall O; Rose G; Seiger A; Strömberg I
Adv Neurol; 1987; 45():85-94. PubMed ID: 3030073
[No Abstract] [Full Text] [Related]
14. Trophism, transplantation, and animal models of Parkinson's disease.
Bankiewicz K; Mandel RJ; Sofroniew MV
Exp Neurol; 1993 Nov; 124(1):140-9. PubMed ID: 8282071
[No Abstract] [Full Text] [Related]
15. Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future.
Hornykiewicz OD
Neurology; 1970 Dec; 20(12):1-5. PubMed ID: 5531292
[No Abstract] [Full Text] [Related]
16. [Modeling of certain symptoms of parkinsonism].
Samoĭlova ZT; Petelin LS; Tret'iakova KA; Chechulin IuS
Patol Fiziol Eksp Ter; 1973; 17(4):78-80. PubMed ID: 4776275
[No Abstract] [Full Text] [Related]
17. Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
Poirier LJ; Langelier P; Bédard P; Boucher R; Larochelle L; Parent A; Roberge AG
Adv Neurol; 1974; 5():5-10. PubMed ID: 4216259
[No Abstract] [Full Text] [Related]
18. Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
Halbhübner K; Herken H; Loos D
Arzneimittelforschung; 1978; 28(10):1743-52. PubMed ID: 39569
[No Abstract] [Full Text] [Related]
19. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism.
Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
J Neural Transm Suppl; 1986; 20():41-6. PubMed ID: 3462325
[TBL] [Abstract][Full Text] [Related]
20. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
Przedborski S; Jackson-Lewis V; Popilskis S; Kostic V; Levivier M; Fahn S; Cadet JL
Neurochirurgie; 1991; 37(6):377-82. PubMed ID: 1780015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]